Back
News

Sementis and Enesi Pharma partner to develop needle-free vaccines

November 2018

Australian biotechnology firm Sementis has entered into a research and development (R&D) partnership with UK-based Enesi Pharma for the development of potential vaccine candidates to treat peanut allergy and chikungunya/Zika infection.

Read more in Pharmaceutical Technology here.